| CodeList |
| CodeListItem |
| NCI attributes |
| OID | Name
(CDISC Submission Value) | DataType
Extensible | NCI Code | CDISC Synonym | CDISC Definition | Preferred Term |
|---|---|---|---|---|---|---|
| CDISC Submission Value [ODM:CodedValue] | ||||||
| CL.C203912.MRCT Center Clinical Research Glossary | MRCT Center Clinical Research Glossary
(MRCT Center Clinical Research Glossary) | text
Extensible: | C203912 | MRCT Center Clinical Research Glossary | The terminology relevant to the plain language glossary of the Multi-Regional Clinical Trial (MRCT) Center of Brigham and Women's Hospital and Harvard. | CDISC MRCT Center Clinical Research Glossary |
| additive effect | C203914 | The combined effect when two or more things are used together. (https://mrctcenter.org/glossaryterm/additive-effect/) | Additive Effect | |||
| adherence | C25729 | Following the study directions and requirements. (https://mrctcenter.org/glossaryterm/adherence/) | Adherence | |||
| adverse event | C41331 | Any health problem that happens during the study. (https://mrctcenter.org/glossaryterm/adverse-event/) | Adverse Event | |||
| adverse reaction | C41332 | A health problem that happens during the study and is reported as possibly caused by the study treatment. (https://mrctcenter.org/glossaryterm/adverse-reaction/) | Adverse Reaction | |||
| anonymize | C142392 | Remove, change, or hide personal details to protect participant privacy. (https://mrctcenter.org/glossaryterm/anonymize/) | Anonymization | |||
| antibody | C16295 | A protein made by the body to fight an illness or infection. (https://mrctcenter.org/glossaryterm/antibody/) | Antibody | |||
| antigen | C268 | A substance that causes the body's immune system to react. (https://mrctcenter.org/glossaryterm/antigen/) | Antigen | |||
| arm | C15538 | A group of participants in a research study who all receive the same study treatment. (https://mrctcenter.org/glossaryterm/arm/) | Protocol Treatment Arm | |||
| assent form | C203934 | A document used to explain the details of a research study to children or people who are unable to give legal consent. (https://mrctcenter.org/glossaryterm/assent-form/) | Assent Form | |||
| assent | C161418 | Willingness to take part in a research study by someone who is not able to give legal consent. (https://mrctcenter.org/glossaryterm/assent/) | Informed Assent | |||
| assessment | C25217 | Information that is collected and analyzed from a study participant. (https://mrctcenter.org/glossaryterm/assessment/) | Assessment | |||
| baseline assessment | C142400 | Information that is collected and analyzed from a study participant at the start of a study. (https://mrctcenter.org/glossaryterm/baseline-assessment/) | Baseline Assessment | |||
| basket trial | C209461 | A research study that tests one study treatment for different diseases and conditions. (https://mrctcenter.org/glossaryterm/basket-trial/) | Basket Trial | |||
| benefits of a research study | C203915 | The ways a research study might help the participant and others. (https://mrctcenter.org/glossaryterm/benefits-of-a-research-study/) | Benefits of a Research Study | |||
| bias (research) | C28232 | Flaws in the way a study is designed, done, or analyzed that lead to one conclusion being favored over another. (https://mrctcenter.org/glossaryterm/research-bias/) | Bias | |||
| biomarker | C16342 | Something in the body that is measured as an indicator of personal health or disease. (https://mrctcenter.org/glossaryterm/biomarker/) | Biomarker | |||
| birth control | C37932 | A way to prevent pregnancy. (https://mrctcenter.org/glossaryterm/birth-control/) | Contraception | |||
| blood draw | C28221 | Taking a sample of blood by using a needle. (https://mrctcenter.org/glossaryterm/blood-draw/) | Phlebotomy | |||
| clinical benefit | C142422 | A health change that researchers measure to show that the study treatment helps the study participants. (https://mrctcenter.org/glossaryterm/clinical-benefit/) | Clinical Benefit | |||
| Clinical Research Coordinator (CRC) | C51811 | A research staff member who helps manage studies. (https://mrctcenter.org/glossaryterm/clinical-research-coordinator-crc/) | Clinical Coordinator | |||
| clinical research | C142435 | A type of science that uses people's data to study health, illness, behaviors, or conditions in careful and defined ways. (https://mrctcenter.org/glossaryterm/clinical-research/) | Clinical Research and Development | |||
| clinical trial | C71104 | A research study that tests drugs, devices and treatments to see if they are safe and work in people. (https://mrctcenter.org/glossaryterm/clinical-trial/) | Clinical Trial | |||
| clinician | C85499 | A health care provider. (https://mrctcenter.org/glossaryterm/clinician/) | Clinician | |||
| cohort | C61512 | A group of study participants that are similar in some way. (https://mrctcenter.org/glossaryterm/cohort/) | Cohort | |||
| Comparative Effectiveness Research (CER) | C203916 | A study comparing two or more treatments. (https://mrctcenter.org/glossaryterm/comparative-effectiveness-research-cer/) | Comparative Effectiveness Research | |||
| comparator | C142458 | Something that is compared to the study treatment. (https://mrctcenter.org/glossaryterm/comparator/) | Comparator | |||
| compensation (study) | C209471 | Money and other forms of payment that may be given to participants for completing study activities. (https://mrctcenter.org/glossaryterm/compensation-study/) | Study Compensation | |||
| compliance | C39490 | Following research requirements. (https://mrctcenter.org/glossaryterm/compliance/) | Patient Compliance | |||
| Computerized Tomography (CT) scan | C17204 | A way to take pictures of the inside of a person's body using a type of radiation and a computer. (https://mrctcenter.org/glossaryterm/computerized-tomography-ct-scan/) | Computed Tomography | |||
| concomitant medications | C70902 | Non-study medicines that are allowed to be taken at the same time as the study treatment. (https://mrctcenter.org/glossaryterm/concomitant-medications/) | Concomitant Agent | |||
| conduct | C153144 | To do a study or procedure. (https://mrctcenter.org/glossaryterm/conduct/) | Study Conduct | |||
| confidence interval | C53324 | The defined range of numbers used to describe where the results are expected to fall. (https://mrctcenter.org/glossaryterm/confidence-interval/) | Confidence Interval | |||
| confidentiality | C16466 | Protecting personal information from people who should not have access. (https://mrctcenter.org/glossaryterm/confidentiality/) | Confidentiality | |||
| confounding | C209462 | When the study outcome is influenced by outside conditions that were not expected by the study researchers. (https://mrctcenter.org/glossaryterm/confounding/) | Confounding Variable | |||
| consent form | C16468 | A document used to explain the planned research before a person decides whether or not to join a study. (https://mrctcenter.org/glossaryterm/consent-form/) | Consent Form | |||
| Contract Research Organization (CRO) | C54148 | A group that is paid by the study sponsor to support research studies. (https://mrctcenter.org/glossaryterm/contract-research-organization-cro/) | Contract Research Organization | |||
| control group | C28143 | The people in a study who do not receive the study treatment or do not have the condition being studied. (https://mrctcenter.org/glossaryterm/control-group/) | Control Group | |||
| correlation | C48834 | When two or more measures are linked. (https://mrctcenter.org/glossaryterm/correlation/) | Correlation | |||
| Data Monitoring Committee/Data and Safety Monitoring Board (DMC/DSMB) | C142489 | An independent group of experts that reviews study data to make sure that patient safety is protected. (https://mrctcenter.org/glossaryterm/data-monitoring-committee-data-and-safety-monitoring) | Data Monitoring Committee | |||
| data | C25474 | Information collected from or about people taking part in a research study. (https://mrctcenter.org/glossaryterm/data/) | Data | |||
| database (research) | C203935 | Information that is collected and organized to be used for research. (https://mrctcenter.org/glossaryterm/database-research/) | Research Database | |||
| discontinue (participant) | C142444 | To remove a study participant from a study. (https://mrctcenter.org/glossaryterm/discontinue-participant/) | Study Subject Discontinuation | |||
| discontinue (study treatment) | C49502 | To stop a study treatment in a participant. (https://mrctcenter.org/glossaryterm/discontinue-study-treatment/) | Drug Withdrawn | |||
| disease progression | C17747 | An illness getting worse over time. (https://mrctcenter.org/glossaryterm/disease-progression/) | Disease Progression | |||
| disease-free survival | C17751 | The length of time after treatment that a person lives without the illness coming back. (https://mrctcenter.org/glossaryterm/disease-free-survival/) | Disease-Free Survival | |||
| dose escalation study | C90475 | A kind of study where increasing amounts of a study treatment are given to different groups to find the best dose. (https://mrctcenter.org/glossaryterm/dose-escalation-study/) | Titration Study | |||
| double-blind study | C15228 | A study that is set up so that the study treatment that each participant receives is not known by the participants or the researchers. (https://mrctcenter.org/glossaryterm/double-blind-study/) | Double Blind Study | |||
| drug holiday | C203919 | A time period decided between the participant and study team when a medication is stopped and then re-started. (https://mrctcenter.org/glossaryterm/drug-holiday/) | Drug Holiday | |||
| drug therapy | C15986 | The use of medicine to treat a disease, condition, or symptom. (https://mrctcenter.org/glossaryterm/drug-therapy/) | Pharmacotherapy | |||
| e-consent (form) | C203920 | An electronic version of an informed consent form. (https://mrctcenter.org/glossaryterm/e-consent-form/) | Electronic Consent Form | |||
| effectiveness | C142522 | How well a treatment works. (https://mrctcenter.org/glossaryterm/effectiveness/) | Effectiveness | |||
| efficacy | C88183 | How well a study treatment works in the study. (https://mrctcenter.org/glossaryterm/efficacy/) | Efficacy | |||
| eligibility criteria | C16112 | The reasons a person can be included in, or excluded from, a study. (https://mrctcenter.org/glossaryterm/eligibility-criteria/) | Clinical Trial Eligibility Criteria | |||
| Emergency Use Authorization (EUA) | C96966 | A process to make a treatment or vaccine available during a public health emergency, before all research is complete, and before full approval is granted. (https://mrctcenter.org/glossaryterm/emergency-use-authorization-eua/) | Emergency Use Authorization | |||
| endpoint | C25212 | A measure of the expected effect of the study treatment. (https://mrctcenter.org/glossaryterm/endpoint/) | End Point | |||
| enroll | C37948 | The action of a participant joining the study after providing informed consent. (https://mrctcenter.org/glossaryterm/enroll/) | Enrollment | |||
| epidemiologist | C17843 | A person who studies where, why, how often, and to what populations health concerns and diseases happen. (https://mrctcenter.org/glossaryterm/epidemiologist/) | Epidemiologist | |||
| equivalence | C142539 | When two or more things in a study are about the same. (https://mrctcenter.org/glossaryterm/equivalence/) | Equivalence Trial | |||
| equivalent (effect) | C203921 | The same or almost the same result. (https://mrctcenter.org/glossaryterm/equivalent-effect/) | Equivalent Effect | |||
| exclusion criteria | C25370 | A list of reasons a person cannot be included in a study. (https://mrctcenter.org/glossaryterm/exclusion-criteria/) | Exclusion Criteria | |||
| expanded access | C98722 | A process for a doctor to request an unapproved treatment for a seriously ill patient. (https://mrctcenter.org/glossaryterm/expanded-access/) | Expanded Access Study | |||
| exploratory research | C147146 | A process to find facts that can guide the design of future studies. (https://mrctcenter.org/glossaryterm/exploratory-research/) | Exploratory Research | |||
| focus group | C154589 | A group interview to learn what people think about a topic. (https://mrctcenter.org/glossaryterm/focus-group/) | Focus Group | |||
| frequency | C25515 | How often something happens over a period of time. (https://mrctcenter.org/glossaryterm/frequency/) | Temporal Frequency | |||
| generalizability | C142429 | How research results can apply to people who were not part of the study. (https://mrctcenter.org/glossaryterm/generalizability/) | Clinical Generalizability | |||
| genetic testing | C15709 | A medical test that could identify a health risk to them or their biological family members by looking at their genes (DNA). (https://mrctcenter.org/glossaryterm/genetic-testing/) | Genetic Testing | |||
| hazard ratio | C93150 | A measure of risk that compares two treatments in the same study. (https://mrctcenter.org/glossaryterm/hazard-ratio/) | Hazard Ratio | |||
| healthy volunteer | C49651 | A study participant who does not have a disease or condition, including the one being studied. (https://mrctcenter.org/glossaryterm/healthy-volunteer/) | Healthy Subject | |||
| hereditary | C27998 | A parent's features and traits being passed to their biological children before birth. (https://mrctcenter.org/glossaryterm/hereditary/) | Hereditary | |||
| hypothesis | C142668 | An idea that is tested in a research study. (https://mrctcenter.org/glossaryterm/hypothesis/) | Research Hypothesis | |||
| immune response | C17930 | The body's reaction to a substance, illness, or infection. (https://mrctcenter.org/glossaryterm/immune-response/) | Immune Response Process | |||
| incidence | C16726 | Number of new cases or events during a period of time. (https://mrctcenter.org/glossaryterm/incidence/) | Incidence | |||
| inclusion criteria | C25532 | A list of requirements a person must meet to take part in a study. (https://mrctcenter.org/glossaryterm/inclusion-criteria/) | Inclusion Criteria | |||
| informed consent | C16735 | The process of learning and discussing the details of a research study before deciding whether to take part. (https://mrctcenter.org/glossaryterm/informed-consent/) | Informed Consent | |||
| infusion | C15388 | A way to give a fluid to the study participant, usually through a vein. (https://mrctcenter.org/glossaryterm/infusion/) | Infusion Procedure | |||
| Institutional Review Board (IRB) | C16741 | A team of people who review studies to protect the rights and welfare of study participants. (https://mrctcenter.org/glossaryterm/institutional-review-board-irb/) | Institutional Review Board | |||
| investigational medicine | C202579 | A treatment or drug that is not yet approved for the condition being studied. (https://mrctcenter.org/glossaryterm/investigational-medicine/) | Investigational Medicinal Product | |||
| Investigational New Drug (IND) application | C96090 | An application to the United States Food & Drug Administration (FDA) to get permission to use a drug in a research study that enrolls people. (https://mrctcenter.org/glossaryterm/investigational-new-drug-ind-application/) | Investigational New Drug Application | |||
| investigational product | C41161 | A drug, device, vaccine or other treatment being tested in a study. (https://mrctcenter.org/glossaryterm/investigational-product/) | Protocol Agent | |||
| investigator | C25936 | A person who leads a research study. (https://mrctcenter.org/glossaryterm/investigator/) | Investigator | |||
| longitudinal study | C15273 | Research that collects data from the same participants over a long time. (https://mrctcenter.org/glossaryterm/longitudinal-study/) | Longitudinal Study | |||
| Magnetic Resonance Imaging (MRI) | C16809 | A way to take pictures of the inside of a person's body with a machine that uses strong magnets and radio waves. (https://mrctcenter.org/glossaryterm/magnetic-resonance-imaging-mri/) | Magnetic Resonance Imaging | |||
| master protocol | C165770 | An overall research plan that guides sub-studies that have their own research questions. (https://mrctcenter.org/glossaryterm/master-protocol/) | Master Protocol | |||
| maximum | C25564 | The most or largest amount. (https://mrctcenter.org/glossaryterm/maximum/) | Maximum | |||
| mean | C53319 | The average. (https://mrctcenter.org/glossaryterm/mean/) | Arithmetic Mean | |||
| median | C28007 | The middle number in a set of numbers when listed in order from lowest to highest. (https://mrctcenter.org/glossaryterm/median/) | Median | |||
| minimal | C25570 | minimum | Very small. (https://mrctcenter.org/glossaryterm/minimal/) | Minimum | ||
| minor | C156663 | Someone considered too young to give legal consent. (https://mrctcenter.org/glossaryterm/minor/) | Minor Person | |||
| monitor | C61256 | To observe, check or evaluate something in a study over time. (https://mrctcenter.org/glossaryterm/monitor/) | Monitoring | |||
| morbidity (rate) | C184382 | The number of people who develop a disease or illness in a group over time. (https://mrctcenter.org/glossaryterm/morbidity-rate/) | Morbidity Rate | |||
| mortality (rate) | C16880 | The number of deaths in a group of people over time. (https://mrctcenter.org/glossaryterm/mortality-rate/) | Mortality Rate | |||
| multicenter trial | C16104 | A study that takes place at more than one research center. (https://mrctcenter.org/glossaryterm/multicenter-trial/) | Multi-Institutional Clinical Trial | |||
| negative test result | C35681 | A test result that shows a person does not have what was tested for. (https://mrctcenter.org/glossaryterm/negative-test-result/) | Negative Test Result | |||
| negligible | C203922 | So small that it has little to no impact. (https://mrctcenter.org/glossaryterm/negligible/) | Negligible | |||
| non-compliance | C201294 | Not following research requirements. (https://mrctcenter.org/glossaryterm/non-compliance/) | Subject Noncompliance | |||
| non-inferiority trial | C184386 | A study to test if a study treatment works about as well as another treatment for the same condition. (https://mrctcenter.org/glossaryterm/non-inferiority-trial/) | Non-Inferiority Trial | |||
| objective | C142450 | A purpose or goal of a study. (https://mrctcenter.org/glossaryterm/objective/) | Clinical Trial Objective | |||
| observational study | C16084 | A study that collects health information about study participants without giving a treatment. (https://mrctcenter.org/glossaryterm/observational-study/) | Observational Study | |||
| odds ratio | C16932 | The chance of a health event happening in one group compared with the chance of the same event happening in another group. (https://mrctcenter.org/glossaryterm/odds-ratio/) | Odds Ratio | |||
| off-label | C125600 | The use of a treatment in a different way or for a condition other than what it is approved for. (https://mrctcenter.org/glossaryterm/off-label/) | Off-Label Treatment | |||
| open-label | C49659 | A type of study where participants and research staff know which treatment participants are being given. (https://mrctcenter.org/glossaryterm/open-label/) | Open Label Study | |||
| outcome (of study) | C204098 | A description of the overall results of the study. (https://mrctcenter.org/glossaryterm/outcome-of-study/) | Study Outcome Description | |||
| outcome measure | C93407 | The way that a study endpoint is measured. (https://mrctcenter.org/glossaryterm/outcome-measure/) | Study Outcome Measurement | |||
| p-value (probability value) | C44185 | A number that researchers use to show that a result did not occur by chance. (https://mrctcenter.org/glossaryterm/p-value-probability-value/) | P-Value | |||
| Patient Reported Outcomes (PROs) | C95401 | The information that patients share about their own health or well-being to answer questions in a study. (https://mrctcenter.org/glossaryterm/patient-reported-outcomes-pros/) | Patient Reported Outcome | |||
| peer review | C16963 | Evaluation by independent experts. (https://mrctcenter.org/glossaryterm/peer-review/) | Peer Review | |||
| Pharmacodynamic (PD) study | C49662 | A study that measures the effects of a drug on the human body. (https://mrctcenter.org/glossaryterm/pharmacodynamic-pd-study/) | Pharmacodynamic Study | |||
| Pharmacokinetic (PK) study | C15299 | A study that measures what happens to a drug in a person's body over time. (https://mrctcenter.org/glossaryterm/pharmacokinetic-pk-study/) | Pharmacokinetics | |||
| pharmacovigilance | C142637 | A process to detect, review, and make decisions about drug safety to protect patients. (https://mrctcenter.org/glossaryterm/pharmacovigilance/) | Pharmacovigilance | |||
| phase | C48281 | A step in the overall clinical research process to test a new drug, device, or treatment. (https://mrctcenter.org/glossaryterm/phase/) | Trial Phase | |||
| pilot study | C15303 | A small study that is done to test a process before starting a larger study. (https://mrctcenter.org/glossaryterm/pilot-study/) | Pilot Study | |||
| placebo | C753 | Something that looks like the treatment being studied, but doesn't contain any medicine. (https://mrctcenter.org/glossaryterm/placebo/) | Placebo | |||
| placebo-controlled study | C203925 | A study with two or more groups where one group is given a placebo. (https://mrctcenter.org/glossaryterm/placebo-controlled-study/) | Placebo-Controlled Study | |||
| platform trial | C209468 | A research study that tests and compares two or more study treatments for a disease or condition, with study treatment groups being added or removed during the study period. (https://mrctcenter.org/glossaryterm/platform-trial/) | Platform Trial | |||
| positive test result | C38758 | A test result that shows a person has what was tested for. (https://mrctcenter.org/glossaryterm/positive-test-result/) | Positive Finding | |||
| post-market surveillance | C142640 | Continuing to collect and analyze information about the risks and benefits of medicine and devices after they have been approved for patient use. (https://mrctcenter.org/glossaryterm/post-market-surveillance/) | Postmarketing Surveillance | |||
| post-trial access | C187706 | When participants can still receive a study treatment after their participation has ended. (https://mrctcenter.org/glossaryterm/post-trial-access/) | Continued Access Study | |||
| preclinical study | C142642 | A study to test a treatment in the lab or in animals before testing it in people. (https://mrctcenter.org/glossaryterm/preclinical-study/) | Preclinical Study | |||
| prevalence | C17010 | Number of known cases or events in a group. (https://mrctcenter.org/glossaryterm/prevalence/) | Prevalence | |||
| primary endpoint | C94496 | A study measure that is used to answer the main research question. (https://mrctcenter.org/glossaryterm/primary-endpoint/) | Primary Endpoint | |||
| probability | C54154 | The likelihood or chance that something might happen. (https://mrctcenter.org/glossaryterm/probability/) | Probability | |||
| procedures (for participants) | C98769 | The activities that participants will be asked to do during the research study. (https://mrctcenter.org/glossaryterm/procedures-for-participants/) | Physical Medical Procedure | |||
| progression-free survival | C28234 | The length of time without a person's illness getting worse. (https://mrctcenter.org/glossaryterm/progression-free-survival/) | Progression-free Survival | |||
| prospective study | C142646 | Research that uses new data collected from participants. (https://mrctcenter.org/glossaryterm/prospective-study/) | Prospective Study | |||
| protocol | C142451 | A complete description of the research plan and procedures. (https://mrctcenter.org/glossaryterm/protocol/) | Clinical Trial Protocol | |||
| proxy | C119264 | A person who is legally allowed to make research decisions for someone else. (https://mrctcenter.org/glossaryterm/proxy/) | Proxy | |||
| pseudonymize | C142654 | Replace personal details with a code so that data are protected. (https://mrctcenter.org/glossaryterm/pseudonymized/) | Pseudonymization | |||
| Quality of Life (QOL) | C17047 | How someone feels and functions day to day. (https://mrctcenter.org/glossaryterm/quality-of-life-qol/) | Quality of Life | |||
| questionnaire | C17048 | A list of questions for study participants to answer as part of the study. (https://mrctcenter.org/glossaryterm/questionnaire/) | Questionnaire | |||
| randomization | C25196 | A way to use chance to place study participants into different study treatment groups. (https://mrctcenter.org/glossaryterm/randomization/) | Randomization | |||
| randomized controlled trial | C46079 | Research that uses chance for participants to be assigned to the study treatment group or a comparison group. (https://mrctcenter.org/glossaryterm/randomized-controlled-trial/) | Randomized Controlled Clinical Trial | |||
| Real World Data (RWD) | C165830 | Information from many different sources used for health research purposes. (https://mrctcenter.org/glossaryterm/real-world-data-rwd/) | Real-world Data | |||
| Real World Evidence (RWE) | C165831 | Findings from analyzing real world data. (https://mrctcenter.org/glossaryterm/real-world-evidence-rwe/) | Real-world Evidence | |||
| registry (study) | C93453 | An organized list of research information. (https://mrctcenter.org/glossaryterm/registry-study/) | Study Registry | |||
| relative risk | C93152 | The chance of a harmful event happening in one study group compared to another. (https://mrctcenter.org/glossaryterm/relative-risk/) | Relative Risk | |||
| repository (research) | C203936 | A collection of participant data and samples stored for future research. (https://mrctcenter.org/glossaryterm/repository-research/) | Research Repository | |||
| results (study) | C203930 | Findings from the study. (https://mrctcenter.org/glossaryterm/results-study/) | Study Results | |||
| retrospective study | C53312 | Research that uses already existing data. (https://mrctcenter.org/glossaryterm/retrospective-study/) | Retrospective Study | |||
| risk-benefit ratio | C203928 | A comparison of the possible bad and potential good things that could happen if a participant joins a research study. (https://mrctcenter.org/glossaryterm/risk-benefit-ratio/) | Risk-Benefit Ratio | |||
| risks of a research study | C142718 | The possible harms of being in a research study. (https://mrctcenter.org/glossaryterm/risks-of-a-research-study/) | Subject Risk | |||
| sample size | C53190 | The number of participants in a study or study group. (https://mrctcenter.org/glossaryterm/sample-size/) | Sample Size | |||
| schedule of assessments | C142678 | A chart that lists the study activities and when they will happen during a study. (https://mrctcenter.org/glossaryterm/schedule-of-assessments/) | Schedule Of Assessments | |||
| screening | C48262 | Tests and questions to find out if a person can join a study. (https://mrctcenter.org/glossaryterm/screening/) | Trial Screening | |||
| secondary endpoint | C139173 | A measure used to answer other important questions in the study that are not the main research question. (https://mrctcenter.org/glossaryterm/secondary-endpoint/) | Secondary Endpoint | |||
| sensitivity (medical test) | C41394 | How well a medical test can accurately identify people who have a disease or trait. (https://mrctcenter.org/glossaryterm/sensitivity-medical-test/) | Diagnostic Sensitivity | |||
| Serious Adverse Event (SAE) | C41335 | A health issue that happens during a study, and can lead to hospital care, lasting medical problems, life-threatening conditions, or death. (https://mrctcenter.org/glossaryterm/serious-adverse-event-sae/) | Serious Adverse Event | |||
| side effect | C2861 | A health change that is not the intended effect of the treatment and usually considered a problem. (https://mrctcenter.org/glossaryterm/side-effect/) | Side Effect | |||
| single-blind study | C28233 | A study that is set up so that the study treatment each participant receives is not known by the participants but is known by the researchers. (https://mrctcenter.org/glossaryterm/single-blind-study/) | Single Blind Study | |||
| specificity (medical test) | C41395 | How well a medical test can accurately identify people who do not have a disease or trait. (https://mrctcenter.org/glossaryterm/specificity-medical-test/) | Diagnostic Specificity | |||
| sponsor | C70793 | The group that is in charge of, or pays for, a research study. (https://dev.mrctcenter.org/glossaryterm/sponsor-3/) | Clinical Study Sponsor | |||
| standard of care | C94396 | The usual treatment given to patients for an illness. (https://mrctcenter.org/glossaryterm/standard-of-care/) | Best Practice | |||
| statistically significant | C61040 | Results that are very unlikely to have occurred by chance. (https://mrctcenter.org/glossaryterm/statistically-significant/) | Statistical Significance | |||
| study design | C15320 | The way a study is set up to answer the study question. (https://mrctcenter.org/glossaryterm/study-design/) | Study Design | |||
| study feasibility | C209473 | How likely it is that a study can be completed. (https://mrctcenter.org/glossaryterm/study-feasibility/) | Study Feasibility | |||
| study intervention | C25218 | A treatment given to the participants in a study. (https://mrctcenter.org/glossaryterm/study-intervention/) | Clinical Intervention or Procedure | |||
| study life cycle | C203929 | The steps of a research study from beginning to end. (https://mrctcenter.org/glossaryterm/study-life-cycle/) | Study Life Cycle | |||
| study participant | C142710 | A person who joins a research study. (https://mrctcenter.org/glossaryterm/study-participant/) | Study Participant | |||
| study population | C70833 | All the participants in a study. (https://mrctcenter.org/glossaryterm/study-population/) | Study Population | |||
| study statistician | C142737 | A person who uses math to help design a study and interpret the data. (https://mrctcenter.org/glossaryterm/study-statistician/) | Trial Statistician | |||
| substudy | C198230 | A study with a smaller group of participants already enrolled in the main study. (https://mrctcenter.org/glossaryterm/substudy/) | Substudy | |||
| superiority trial | C142722 | A study to test if a study treatment works better than another treatment for the same condition. (https://mrctcenter.org/glossaryterm/superiority-trial/) | Superiority Trial | |||
| synergistic effect | C203931 | When two or more things combined have a greater effect than when their individual effects are added together. (https://mrctcenter.org/glossaryterm/synergistic-effect/) | Synergistic Effect | |||
| tolerability | C203932 | How much a participant or group of participants can accept a study treatment's unwanted effects so they can keep taking it. (https://mrctcenter.org/glossaryterm/tolerability/) | Study Intervention Tolerability | |||
| treatment effect | C209469 | How much a study treatment changes a condition, symptom, or function. ((https://mrctcenter.org/glossaryterm/treatment-effect/) | Treatment Effect | |||
| umbrella trial | C209470 | A research study that tests and compares two or more study treatments for one disease or condition. (https://mrctcenter.org/glossaryterm/umbrella-trial/) | Umbrella Trial | |||
| voluntary participation | C203933 | Choosing to participate in research without feeling pressured. (https://mrctcenter.org/glossaryterm/voluntary-participation/) | Voluntary Participation | |||
| wash-out | C42872 | A time before starting a study treatment when a person stops taking other medicines. (https://mrctcenter.org/glossaryterm/wash-out/) | Washout Period | |||
| withdraw | C49634 | To stop being a participant in a study. (https://mrctcenter.org/glossaryterm/withdraw/) | Withdrawal by Subject | |||
| X-ray | C38101 | A way of taking pictures of the inside of a person's body using X-ray radiation. (https://mrctcenter.org/glossaryterm/x-ray/) | X-Ray Imaging | |||
| Back to top | ||||||